Pfizer Inc. has received a $1.95 billion order from the U.S. government for 100 million doses of an experimental COVID-19 vaccine. Pfizer’s facility in Chesterfield, Missouri, is one of three of the company’s sites identified as manufacturing centers for COVID-19 vaccine production.
“We’ve been committed to making the impossible possible by working tirelessly to develop and produce in record time a safe and effective vaccine to help bring an end to this global health crisis,” said Dr. Albert Bourla, Pfizer chairman and CEO. “We made the early decision to begin clinical work and large-scale manufacturing at our own risk to ensure that product would be available immediately if our clinical trials prove successful and an Emergency Use Authorization is granted.”
The company said the $1.95 billion deal with the U.S. Department of Health and Human Services and the Department of Defense calls for Pfizer, and German health innovation company BioNTech, to initially deliver up to 100 million doses of their jointly produced BNT162 COVID-19 vaccine. The government can then order up to 500 million more doses.
The companies said the BNT162 vaccine candidates are undergoing clinical studies and are not currently approved for distribution anywhere in the world. But if the ongoing studies are successful, Pfizer and BioNTech said they expect to be ready to seek Emergency Use Authorization or some form of regulatory approval as early as October 2020.
The companies currently expect to manufacture globally up to 100 million doses by the end of 2020 and potentially more than 1.3 billion doses by the end of 2021. The order is part of the U.S. government’s “Operation Warp Speed” program goal to begin delivering 300 million doses of a vaccine for COVID-19 in 2021.
What Next?
Kansas City, Missouri, is the third best city in the U.S. for remote workers, according to a recent study. The study looked at factors including cost of living, availability of high-speed ... Read More
Pfizer Inc. has received a $1.95 billion order from the U.S. government for 100 million doses of an experimental COVID-19 vaccine. Pfizer’s facility in Chesterfield, Missouri, is one of three of ... Read More
Armstrong World Industries (AWI) recently announced plans to invest nearly $8 million to grow its Architectural Components Group Inc. (ACGI) wood ceiling and wall operations in Marshfield, Missouri. The 50,000 sq. ... Read More
Missouri’s Washington University School of Medicine and the St. Louis University Center for Vaccine Development are joining clinical trials organized by the National Institute of Allergy and Infectious Diseases in response ... Read More
A scientist at the Donald Danforth Plant Science Center in St. Louis, Missouri, has been awarded $1.4 million in federal funding to advance a fully automated crop monitoring platform. Danforth Center ... Read More
R&S Machining Inc., an aerospace manufacturer, has announced plans to invest $13.5 million to grow their presence, and create 60 new jobs, in Missouri. The investment will grow two of the ... Read More
Chewy, Inc., a pet supply company, announced the opening of a new 800,000 sq. ft. eCommerce fulfillment center in Belton, Missouri. The online retailer of pet food and pet-related products say ... Read More
Kansas City, Missouri, is high on the list for officials guiding where companies locate new offices and facilities, according to a new survey. The Missouri city was among 11 mid-sized cities ... Read More
The United States Air Force has awarded Boeing a $1.2 billion contract for Missouri-made F-15EX fighter jets. The new fighters, manufactured at Boeing’s Defense Space & Security plant in St. Louis, ... Read More
Missouri-based customer relationship management (CRM) company, Less Annoying CRM, has been ranked the best CRM software of 2020, by US News. Less Annoying CRM is software built specifically for small businesses, ... Read More